BMY241101C59000
- 0.01
- -0.05-83.33%
Bristol-Myers Squibb Newsroom
Bristol Myers Shares New Data on COBENFY for Schizophrenia at Psych Congress, Highlighting Long-Term Safety and Patient Satisfaction
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024
Apple, Microsoft, Exxon, and More Stocks to Watch
Heard on the Street: Pfizer's Activist Battle Might Fizzle -- but Its Stock Probably Won't -- WSJ
Earnings Preview: BMY to Report Financial Results Pre-market on October 31
$Bristol-Myers Squibb(BMY.US)$ is scheduled to release its financial results pre-market on October 31 ET. Earnings PreviewAnalysts estimate $Bristol-Myers Squibb(BMY.US)$ to post revenue of USD11.25
Bristol-Myers Squibb Analyst Ratings
Express News | Bristol-Myers Squibb : Deutsche Bank Raises Target Price to $48 From $45
Citi Downgrades Bristol-Myers Squibb(BMY.US) to Hold Rating, Cuts Target Price to $55
Express News | Bristol-Myers Squibb Co : Citigroup Cuts to Neutral From Buy
Chen Jining meets with the Chief Executive Officer of Bristol-Myers Squibb in the USA, Giovanni Caforio.
This morning, the Secretary of the Shanghai Municipal Party Committee, Chen Jinong, met with the CEO Bosch of the American Bristol-Myers Squibb. Chen Jinong said, welcoming Bristol-Myers Squibb to bring more new projects, new technologies, and new models to Shanghai on the basis of existing good cooperation, further deepen clinical research, promote new drug development, layout production manufacturing, participate in health insurance development, better benefit the general patients, and help the high-quality development of the biomedical industry in Shanghai.
We Think Bristol-Myers Squibb (NYSE:BMY) Can Stay On Top Of Its Debt
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
Why Is Evotec Stock Gaining Today?
Sector Update: Health Care Stocks Steady Premarket Wednesday
Redwire Announced That It Is Launching An Investigation To The International Space Station In Partnership With Global Leading Biopharmaceutical Company Bristol Myers Squibb To Study Model Small Molecule Compounds
Express News | Redwire: Launching Investigation to Iss With Bms to Study Model Small Molecule Compounds Using Co's Pil-Box
Leerink Partners Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Announces Target Price $53
Evotec And Bristol Myers Squibb Strengthen Proteomics Partnership With $50M Payment, Expanding Molecular Glue Pipeline
Bristol-Myers Squibb: Navigating Financial Adjustments and Competitive Pressures Amidst a Hold Rating